Condition
Multiple Chemical Sensitivity
Total Trials
4
Recruiting
0
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04935307Not ApplicableActive Not Recruiting
Central Processing of Odour Stimuli in Patients With Functional Somatic Disorder, MCS or Post Covid Compared to Healthy Controls
NCT01834781Not ApplicableCompletedPrimary
Pulsed Electromagnetic Fields for Multiple Chemical Sensitivity
NCT00810329Completed
Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome
NCT01240395Not ApplicableCompletedPrimary
Mindfulness-based Cognitive Therapy for Individuals With Multiple Chemical Sensitivity
Showing all 4 trials